|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-7-19
|
|
pubmed:abstractText |
To assess the impact of HIV-1 protease and reverse transcriptase (RT) mutations, and pharmacokinetic parameters on virological responses to nelfinavir (NFV)-containing highly active antiretroviral therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1331-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12131209-Adult,
pubmed-meshheading:12131209-Anti-HIV Agents,
pubmed-meshheading:12131209-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:12131209-CD4 Lymphocyte Count,
pubmed-meshheading:12131209-Cohort Studies,
pubmed-meshheading:12131209-Drug Resistance, Viral,
pubmed-meshheading:12131209-Drug Therapy, Combination,
pubmed-meshheading:12131209-Female,
pubmed-meshheading:12131209-Genotype,
pubmed-meshheading:12131209-HIV Infections,
pubmed-meshheading:12131209-HIV Protease,
pubmed-meshheading:12131209-HIV Protease Inhibitors,
pubmed-meshheading:12131209-HIV-1,
pubmed-meshheading:12131209-Humans,
pubmed-meshheading:12131209-Male,
pubmed-meshheading:12131209-Multivariate Analysis,
pubmed-meshheading:12131209-Mutation,
pubmed-meshheading:12131209-Nelfinavir,
pubmed-meshheading:12131209-RNA-Directed DNA Polymerase,
pubmed-meshheading:12131209-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).
|
|
pubmed:affiliation |
Department of Virology, Bordeaux University Hospital, Bordeaux, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
